Translational Control has become a major focus of attention in the field of gene regulation and extends to many fields including developmental biology, neurobiology, cell physiology and disease. The discovery of miRNAs opened a new frontier and has been complimented with the finding of new non-coding RNA molecules and the establishment of novel powerful high-throughput techniques, both of which will be central within the conference. With the increasing appreciation for the integration between different steps in the gene expression pathway, the conference will also explore the latest work on the interfaces between translational control and mRNA turnover, RNA localization and splicing/nonsense-mediated decay.
The conference will continue to promote communication between experts in the field of translation with those from a scientifically related field that have traditionally held separate meetings on the structure and function of the ribosome. Finally, our biochemical understanding of the translation process is progressing rapidly, and is uncovering hidden layers of regulation including isoforms of translation initiation factors with distinct activities and initiation at non-AUG codons. The latest findings regarding these processes will be featured prominently within the conference. We thus believe that the conference promises to be timely, cutting-edge and of broad interest.
- Maria Barna – University of California-San Francisco, USA
- Mordechai Choder – Technion — Israel Institute of Technology, Israel
- Markus Landthaler – MDC Berlin, Germany
- William C. Merrick – Case Western Reserve University, USA
- Thomas Preiss – Australian National University, Australia
- Vasudevan Shobha – Massachussets General Hospital Cancer Center, USA
- Christian Spahn – Institute of Medical Physics and Biophysics Berlin, Germany
EMBL Corporate Partnership Programme Fellowships
A limited number of EMBL Advanced Training Centre Corporate Partnership Programme (CPP) fellowships are available for this meeting in the form of both Registration Fee Waivers and Travel Grants. You may apply for an EMBL CPP Registration Fee Waiver and/or Travel Grant when submitting your abstract. Whilst submitting your abstract (Step 2 after you have registered your personal details) you will also be asked to complete a field with the name of your lab and the country in which it is based, and to answer some questions to detail your reasons for requesting this fellowship. A statement of support from your budget holding supervisor explaining a) their support for your attendance and b) support provided by the laboratory budget is required to complete the application.
Registration Fee Waiver: The sum that you have paid to attend the meeting will be reimbursed.
Travel Grant: Up to €400 for participants travelling from the European continent and up to €1000 for participants travelling from outside Europe (receipts of travel will be submitted to the EMBL Course and Conference Office and the exact sum for travel expenses up to the cap will be reimbursed)
Participants coming from the following countries will be given priority for travel grants:
Albania, Armenia, Azerbaijan, Bulgaria, Belarus, Bosnia and Herzegovina, Czech Republic, Cyprus, Estonia, Georgia, Hungary, Kazakhstan, Kosovo, Kyrgyzstan, Lithuania, Macedonia, Malta, Moldova, Montenegro, Poland, Romania, Russia, Slovakia, Slovenia, Serbia, Ukraine and Turkey. Africa, South and Central America and Asia (excluding China, Japan, Singapore, and South Korea).
The scientific organisers will select the recipients of all fellowships during the abstract selection process.
If you are awarded a fellowship, you will be notified after the completion of the abstract selection. This is usually 8 weeks before the event start date. Please note that you must pay your registration fee by the payment deadline (6 weeks before the event start date). The EMBL Course & Conference Office will request your bank details and reimburse the registration fees after the event. Travel Grants can only be reimbursed after the event once the receipts have been submitted.